Best Growth Stocks to Buy for February 10th

Shares of psychedelics-related stocks climbed in early trade on Monday after US president Donald Trump signed an executive order aimed at accelerating research into psychedelic-assisted therapies and expanding patient access for certain serious mental health conditions, including post-traumatic stress disorder (PTSD) and treatment-resistant depression. The executive order, signed by Trump on Saturday, directs the US Food and Drug Administration (FDA) Commissioner to prioritize review pathways for psychedelic drugs that have received Breakthrough Therapy designation for serious mental illnesses and meet criteria under a national voucher program designed to speed regulatory review.

Nvidia remains well positioned to benefit from the AI infrastructure buildout. Broadcom has a huge opportunity in front of it with custom AI chips.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.